ARTICLE | Company News
Immune Network, InNexus Corp. deal
December 10, 2001 8:00 AM UTC
IMM granted a sublicense option allowing InNexus to apply SuperAntibody technology to IMMKF’s hNM01 and 1F7 antibodies to treat HIV infection/AIDS. SuperAntibodies are designed to add binding strength...